Clinical endpoint
Clinical Endpoint[edit]
A clinical endpoint is a term used in clinical trials to refer to a measure that reflects how a patient feels, functions, or survives. Clinical endpoints are critical in determining the efficacy and safety of a new treatment or intervention.
Types of Clinical Endpoints[edit]
Clinical endpoints can be classified into several types:
- Primary Endpoint: The main result that is measured at the end of a study to see if the treatment worked (e.g., survival rate, reduction in symptoms).
- Secondary Endpoint: Additional effects of the treatment that are also of interest but are not the main focus of the study (e.g., quality of life, side effects).
- Surrogate Endpoint: A substitute for a clinical endpoint that measures a biological or physical sign that is expected to predict clinical benefit (e.g., blood pressure, cholesterol levels).
Importance in Clinical Trials[edit]
Clinical endpoints are essential for the following reasons:
- They provide a clear and measurable outcome to assess the effectiveness of a treatment.
- They help in the regulatory approval process by providing evidence of the treatment's benefits.
- They guide healthcare providers in making informed decisions about patient care.
Selection of Clinical Endpoints[edit]
The selection of appropriate clinical endpoints is crucial and depends on several factors:
- The nature of the disease or condition being studied.
- The expected effect of the treatment.
- The feasibility of measuring the endpoint accurately and reliably.
Examples of Clinical Endpoints[edit]
- In oncology trials, common clinical endpoints include overall survival and progression-free survival.
- In cardiology trials, endpoints may include myocardial infarction and stroke.
- In infectious disease trials, endpoints often include infection rate and mortality rate.
Challenges in Using Clinical Endpoints[edit]
Some challenges associated with clinical endpoints include:
- Variability in how endpoints are measured and reported.
- The need for long-term follow-up to observe certain endpoints.
- Ethical considerations in withholding treatment to measure endpoints.
Related Pages[edit]
- Clinical trial
- Surrogate endpoint
- Primary endpoint
- Secondary endpoint
- Overall survival
- Progression-free survival
- Myocardial infarction
- Stroke
- Infection rate
- Mortality rate
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian